|
1
|
Lin L, Wang G, Ming J, Meng X, Han B, Sun
B, Cai J and Jiang C: Analysis of expression and prognostic
significance of vimentin and the response to temozolomide in glioma
patients. Tumour Biol. 37:15333–15339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thompson EG and Sontheimer H: A role for
ion channels in perivascular glioma invasion. Eur Biophys J.
45:635–648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho VK, Reijneveld JC, Enting RH, Bienfait
HP, Robe P, Baumert BG and Visser O: Dutch Society for
Neuro-Oncology (LWNO): Changing incidence and improved survival of
gliomas. Eur J Cancer. 50:2309–2318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang AL, Zhang TT, Zhou N, Wu CY, Lin MH
and Liu YJ: MiRNA-10b sponge: An anti-breast cancer study in vitro.
Oncol Rep. 35:1950–1958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44(D1): D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu J, Wang S, Zhang W, Qiu J, Shan Y,
Yang D and Shen B: Screening key microRNAs for castration-resistant
prostate cancer based on miRNA/mRNA functional synergistic network.
Oncotarget. 6:43819–43830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao R, Zhou M, Wang H, Xiong W, Li X and
Li G: MiRNA regulatory mechanism in tumor initiation and
progression. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 38:1282–1288.
2013.(In Chinese). PubMed/NCBI
|
|
8
|
Garzia L, Andolfo I, Cusanelli E, Marino
N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L,
Esposito S, et al: MicroRNA-199b-5p impairs cancer stem cells
through negative regulation of HES1 in medulloblastoma. PLoS One.
4:e49982009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costa FF, Bischof JM, Vanin EF, Lulla RR,
Wang M, Sredni ST, Rajaram V, Bonaldo MF, Wang D, Goldman S, et al:
Identification of microRNAs as potential prognostic markers in
ependymoma. PLoS One. 6:e251142011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang L, Mao P, Song L, Wu J, Huang J, Lin
C, Yuan J, Qu L, Cheng SY and Li J: miR-182 as a prognostic marker
for glioma progression and patient survival. Am J Pathol.
177:29–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gal H, Pandi G, Kanner AA, Ram Z,
Lithwick-Yanai G, Amariglio N, Rechavi G and Givol D: MIR-451 and
Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
Biochem Biophys Res Commun. 376:86–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deakin NE and Chaplain MA: Mathematical
modeling of cancer invasion: The role of membrane-bound matrix
metalloproteinases. Front Oncol. 3:702013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fillmore HL, VanMeter TE and Broaddus WC:
Membrane-type matrix metalloproteinases (MT-MMPs): Expression and
function during glioma invasion. J Neurooncol. 53:187–202. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ram RR, Mendiratta S, Bodemann BO, Torres
MJ, Eskiocak U and White MA: RASSF1A inactivation unleashes a tumor
suppressor/oncogene cascade with context-dependent consequences on
cell cycle progression. Mol Cell Biol. 34:2350–2358. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan H and Gao Y: MicroRNA-1908 is
upregulated in human osteosarcoma and regulates cell proliferation
and migration by repressing PTEN expression. Oncol Rep.
34:2706–2714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim HR, Shin CH, Lee H, Choi KH, Nam DH,
Ohn T and Kim HH: MicroRNA-1908-5p contributes to the oncogenic
function of the splicing factor SRSF3. Oncotarget. 8:8342–8355.
2017.PubMed/NCBI
|
|
19
|
Jin JC, Jin XL, Zhang X, Piao YS and Liu
SP: Effect of OSW-1 on microRNA expression profiles of hepatoma
cells and functions of novel microRNAs. Mol Med Rep. 7:1831–1837.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lian D, Wang ZZ and Liu NS: MicroRNA-1908
is a biomarker for poor prognosis in human osteosarcoma. Eur Rev
Med Pharmacol Sci. 20:1258–1262. 2016.PubMed/NCBI
|
|
21
|
Xia X, Li Y, Wang W, Tang F, Tan J, Sun L,
Li Q, Sun L, Tang B and He S: MicroRNA-1908 functions as a
glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
Mol Cancer. 14:1542015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shou J, Gu S and Gu W: Identification of
dysregulated miRNAs and their regulatory signature in glioma
patients using the partial least squares method. Exp Ther Med.
9:167–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aigner A: MicroRNAs (miRNAs) in cancer
invasion and metastasis: Therapeutic approaches based on
metastasis-related miRNAs. J Mol Med (Berl). 89:445–457. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mamoori A, Gopalan V, Smith RA and Lam AK:
Modulatory roles of microRNAs in the regulation of different
signalling pathways in large bowel cancer stem cells. Biol Cell.
108:51–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yde CW, Sehested A, Mateu-Regué À, Østrup
O, Scheie D, Nysom K, Nielsen FC and Rossing M: A new NFIA:RAF1
fusion activating the MAPK pathway in pilocytic astrocytoma. Cancer
Genet. 209:440–444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu
Z, Liu T and Hu F: miR-195 is a key regulator of Raf1 in thyroid
cancer. Onco Targets Ther. 8:3021–3028. 2015. View Article : Google Scholar : PubMed/NCBI
|
